Back to Authors

Khatcheressian, James

A5027092635 | I4210098033

Mayo Clinic

Virginia Cancer Institute

Citations 2

CALGB 70604 (Alliance): A randomized phase III study of standard dosing vs. longer interval dosing of zoledronic acid in metastatic cancer.

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 9501-9501

10.1200/jco.2015.33.15_suppl.9501

Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases

JAMA | January 5, 2017 | Volume: 317 | Issue: 1 | Pages: 48

10.1001/jama.2016.19425 | PMID 28030702